OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

8632	Companies
144762	Keywords
80437	Articles
77437	Press releases

Home
Companies
OXURION

BRIEF

published on 04/25/2025 at 18:35, 4 days 14 hours ago

Oxurion Stops 2024 Transaction and Continues Negotiations for New Acquisition

Acquisition Negotiations CRO Oxurion Biometrics
BRIEF

published on 04/25/2025 at 18:35, 4 days 14 hours ago

Oxurion Arrête une Transaction de 2024 et Continue les Négociations pour une Nouvelle Acquisition

Acquisition Négociations CRO Oxurion Biométrie
PRESS RELEASE

published on 04/25/2025 at 18:30, 4 days 14 hours ago

Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025
Oxurion NV halts acquisition of French CRO, pursues deal with biometrics CRO to expand capabilities in clinical data management. Progress updates to follow

Acquisition CRO Oxurion NV Clinical Data Management Biometrics
PRESS RELEASE

published on 04/25/2025 at 18:30, 4 days 14 hours ago

Oxurion kondigt stopzetting aan van de transactie van juli 2024 en bevestigt de voortzetting van de gesprekken over het overnameproject aangekondigd in maart 2025
Oxurion NV (Euronext Brussels: OXUR) stops negotiations for majority stake acquisition in French CRO, continues talks for majority stake in CRO specializing in biometrics and advanced data management. Market updates to follow

Majority Stake Acquisition Clinical Studies CRO Oxurion NV Biometrics
BRIEF

published on 04/11/2025 at 20:05, 18 days 13 hours ago

Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting

Forward-looking Statements Annual Report 2024 Ophthalmic Therapies Shareholders' Meetings Oxurion NV
BRIEF

published on 04/11/2025 at 20:05, 18 days 13 hours ago

Oxurion Publie son Rapport Annuel 2024 et Convoque son Assemblée Générale

Déclarations Prospectives Rapport Annuel 2024 Oxurion NV Thérapies Ophtalmologiques Assemblées Actionnaires
PRESS RELEASE

published on 04/11/2025 at 20:05, 18 days 13 hours ago

Publication Annual Report - Annual Shareholders' Meeting
Oxurion NV releases its annual report for the financial year 2024 and convenes its Annual Shareholders' Meeting in Leuven, Belgium. Developing ophthalmic therapies for retinal disease

Shareholders' Meeting Annual Report Ophthalmic Therapies Oxurion NV Retinal Disease
PRESS RELEASE

published on 04/11/2025 at 20:00, 18 days 13 hours ago

Publicatie jaarverslag - Jaarlijkse Algemene Vergadering
Oxurion NV publice son rapport annuel 2024, convoque son assemblée annuelle d'actionnaires et se concentre sur les thérapies ophtalmologiques

Rapport Annuel 2024 Oxurion NV Assemblée Annuelle Thérapies Ophtalmologiques Biofarmaceutique
BRIEF

published on 04/04/2025 at 14:05, 25 days 19 hours ago

Report de l'Assemblée Générale d'Oxurion

Assemblée Générale Biopharmaceutique Report Oxurion Thérapies Ophtalmologiques
BRIEF

published on 04/04/2025 at 14:05, 25 days 19 hours ago

Oxurion General Meeting Postponed

General Meeting Biopharmaceuticals Report Ophthalmic Therapies Oxurion

1 2 ... 7

Accesswire

Published on 04/30/2025 at 08:00, 1 hour 21 minutes ago

Argo Blockchain PLC Announces Financial Update and Listing Suspension Request
Published on 04/30/2025 at 03:05, 6 hours 16 minutes ago

Quarterly Activities and Cashflow Report
Published on 04/30/2025 at 01:25, 7 hours 56 minutes ago

UniDoc Provides Update on Marketing Engagement
Published on 04/30/2025 at 01:20, 8 hours 1 minute ago

Electric Metals (USA) Limited Closes $3.0 Million Non-Brokered Private Placement Led by Eric Sprott and Crescat Capital
Published on 04/29/2025 at 23:30, 9 hours 51 minutes ago

Electric Royalties Announces Marketing Activities and Long-Term Incentive Grants

View all ACCESSWIRE

EQS Group

Published on 04/30/2025 at 09:00, 20 minutes ago

Original-Research: 029 Group SE (von NuWays AG): SELL
Published on 04/30/2025 at 09:00, 20 minutes ago

Le retrait anticipé de la fortune de la CP met en péril la capacité à assumer des hypothèques
Published on 04/30/2025 at 09:00, 21 minutes ago

JOST successfully places promissory note loan for EUR 320 million
Published on 04/30/2025 at 09:00, 21 minutes ago

SANHA GmbH & Co. KG reports positive business performance in the first quarter of 2025
Published on 04/30/2025 at 08:58, 22 minutes ago

After a challenging 2024 financial year, the increased use of AI and digitalization as well as a far-reaching restructuring program pave the way for a return to profitability in 2025

Les Echos

Published on 04/30/2025 at 08:30, 51 minutes ago

Mise à disposition des documents préparatoires à l’Assemblée Générale mixte
Published on 04/29/2025 at 19:13, 14 hours 8 minutes ago

Rapport Financier Annuel - 31/12/2024
Published on 04/29/2025 at 19:02, 14 hours 18 minutes ago

LNA SANTE : Mise à disposition du document d'enregistrement universel 2024
Published on 04/29/2025 at 18:22, 14 hours 59 minutes ago

BIO-INOX : RESULTATS ANNUELS 2024 : CHIFFRE D'AFFAIRES +16,4% - RESULTAT NET +75,1%
Published on 04/29/2025 at 18:12, 15 hours 9 minutes ago

250429 BENETEAU Avis de mise à disposition de documents

View all LES ECHOS COMFI WIRE